niclofolan and Hemoptysis

niclofolan has been researched along with Hemoptysis* in 2 studies

Other Studies

2 other study(ies) available for niclofolan and Hemoptysis

ArticleYear
Pulmonary paragonimiasis in Cameroon.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1982, Volume: 76, Issue:6

    Paragonimus africanus has been known to be endemic in the Bakossi area of Meme Division of Cameroon since it was first described in 1952. After a lapse of 25 years, exploratory work was undertaken in the area (but not in the same villages) to study the prevalence of the disease, to record the common presenting symptoms, to make a number of paraclinical examinations, to assess the beliefs and attitudes of the people towards the disease and the possible reasons for its persistent endemicity in that area and to carry out a therapeutic trial with Niclofolan (Bilevon). The disease was found to have a prevalence of 5% with a higher prevalence among those less than 20 years old. Boys were more affected than girls. The population did not appear to recognize the disease which they confused with tuberculosis. The disease was contracted by eating improperly cooked crabs, the intermediate host. The therapeutic trial with Bilevon given orally as a single dose was completely successful. This study showed that paragonimiasis must be considered seriously in the differential diagnosis of tuberculosis in this area and that a study on a much wider scale is required to establish the real extent of the disease.

    Topics: Adolescent; Adult; Cameroon; Child; Child, Preschool; Diagnosis, Differential; Female; Hemoptysis; Humans; Infant; Lung Diseases, Parasitic; Male; Middle Aged; Niclofolan; Paragonimiasis; Tuberculosis, Pulmonary

1982
Single dose therapy of paragonimiasis with menichlopholan.
    The American journal of tropical medicine and hygiene, 1977, Volume: 26, Issue:4

    Menichlopholan, biphenyl compound, in a single dose of 2 mg/kg body weight, gave a 73%-90% cure rate in the treatment of pulmonary infections due to Paragonimus uterobilateralis at two centers in Nigeria. Ninety-five patients were followed up for 4 months, and 58 for 1 year. Side effects of the drug included sweating and body pains, but there was no significnat biochemical or hematological evidence of damage to the internal organs. The advantages of single dose therapy are likely to make menichlopholan the treatment of choice for paragonimiasis in Africa, and probably elsewhere.

    Topics: Adolescent; Adult; Bithionol; Child; Female; Hemoptysis; Humans; Liver Function Tests; Lung; Lung Diseases, Parasitic; Male; Middle Aged; Niclofolan; Nitrophenols; Paragonimiasis; Parasite Egg Count; Radiography

1977